ライフサイエンスコーパス: reduction mammoplasty

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 the majority of normal tissue obtained from reduction mammoplasty.

2 l human breast epithelial cells (HBECs) from reduction mammoplasty.

3 X-2 expression in a series of specimens from reduction mammoplasty, adenosis, ductal carcinoma in sit

4 stry in 17 normal breast tissue samples from reduction mammoplasties and in two independent tissue mi

5 s, including breast fibroblasts derived from reduction mammoplasty and tumor tissues, and human umbil

6 elial ducts within tumors and in tissue from reduction mammoplasties, and by epithelial-derived tumor

7 t cells separately purified from a set of 10 reduction mammoplasties by using a double antibody magne

8 n approach combining partial mastectomy with reduction mammoplasty could provide a safe oncologic pro

9 Whereas inclusion of normal reduction mammoplasty fibroblasts inhibit or retard morp

10 Samples from bilateral reduction mammoplasty from 10 women without any clinical

11 6, and 40), established from tissue taken at reduction mammoplasty from three individuals.

12 normalities were also selected as a control (reduction mammoplasty group).

13 She underwent bilateral reduction mammoplasty in June 1995 to treat progressive

14 ormal mammary epithelial cells enriched from reduction mammoplasties (n = 9).

15 d either from breast cancer patients or from reduction mammoplasty operations expressed comparable es

16 ng human breast epithelial cells from either reduction mammoplasty or nonmalignant breast cell lines,

17 undergoing partial mastectomy and concurrent reduction mammoplasty performed at our institution from

18 consecutive simultaneous partial mastectomy/reduction mammoplasty procedures were performed in 79 pa

19 amples from 29 noncancer patients undergoing reduction mammoplasty served as controls.

20 aneous fat and evaluation of the skin during reduction mammoplasty surgery in two patients.

21 A partial mastectomy with concurrent reduction mammoplasty technique is a viable option for b

22 at varying degrees of risk (those undergoing reduction mammoplasties, those with atypical hyperplasti

23 ammary epithelial cells (HMEC) isolated from reduction mammoplasty tissue are proliferative for sever

24 mmary epithelial cells (HMECs) isolated from reduction mammoplasty tissue of seven individual donors.

25 lial cell (HMEC) culture model, derived from reduction mammoplasty tissue, and found that ectopic exp

26 ting functionally normal breast tissues from reduction mammoplasty tissues, in what we term the human

27 east tissue from healthy patients undergoing reduction mammoplasty was also studied.

28 ly removed from 40 women undergoing elective reduction mammoplasty were extracted by a solid-phase pr

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。